Evidence map›Paper›PMID 28135259›Full record

ArticleNature methods2017

Building ProteomeTools based on a complete synthetic human proteome.

Daniel P Zolg, Mathias Wilhelm, Karsten Schnatbaum, Johannes Zerweck, Tobias Knaute, Bernard Delanghe, Derek J Bailey, Siegfried Gessulat, Hans-Christian Ehrlich, Maximilian Weininger and 14 more

Abstract read
In one paragraph

Article in Nature methods, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 110 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
110citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

110 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

50 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Daniel P ZolgChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Mathias WilhelmChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Karsten SchnatbaumJPT Peptide Technologies GmbH, Berlin, Germany.
Johannes ZerweckJPT Peptide Technologies GmbH, Berlin, Germany.
Tobias KnauteJPT Peptide Technologies GmbH, Berlin, Germany.
Bernard DelangheThermo Fisher Scientific, Bremen, Germany.
Derek J BaileyThermo Fisher Scientific, San Jose, California, USA.
Siegfried GessulatChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Hans-Christian EhrlichSAP SE, Potsdam, Germany.
Maximilian WeiningerChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Peng YuChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Judith SchleglSAP SE, Walldorf, Germany.
Karl KramerChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Tobias SchmidtChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.
Ulrike KusebauchInstitute for Systems Biology, Seattle, Washington, USA.
Eric W DeutschInstitute for Systems Biology, Seattle, Washington, USA.
Ruedi AebersoldDepartment of Biology, Institute of Molecular Systems Biology, ETH, Zürich, Switzerland.
Robert L MoritzInstitute for Systems Biology, Seattle, Washington, USA.
Holger WenschuhJPT Peptide Technologies GmbH, Berlin, Germany.
Thomas MoehringThermo Fisher Scientific, Bremen, Germany.
Stephan AicheSAP SE, Potsdam, Germany.
Andreas HuhmerThermo Fisher Scientific, San Jose, California, USA.
Ulf ReimerJPT Peptide Technologies GmbH, Berlin, Germany.
Bernhard KusterChair of Proteomics and Bioanalytics, Technical University of Munich, Freising, Germany.ORCID 0000-0002-9094-1677

Funding

Quantitative Systems BiologyP50GM076547 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI BALIGA, NITIN S · 2006 to 2016
$30.6M
Shortening the development cycle time of Trans Proteomic Pipeline tools with high performance computingR01GM087221 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC, MORITZ, ROBERT L · 2010 to 2021
$6.0M
Complete Human Peptide- and MRM-AtlasRC2HG005805 · NHGRI · INSTITUTE FOR SYSTEMS BIOLOGY · PI HOOD, LEROY E, MORITZ, ROBERT L · 2009 to 2010
$4.6M
FAIMS-Selected Reaction Monitoring to Quantitative Protein Networks in DiseaseS10RR027584 · NCRR · INSTITUTE FOR SYSTEMS BIOLOGY · PI MORITZ, ROBERT L · 2011 to 2011
$576k
European Research Council 233226European Research Council 670821NCRR NIH HHS S10 RR027584NHGRI NIH HHS RC2 HG005805NIGMS NIH HHS P50 GM076547NIGMS NIH HHS R01 GM087221
6 · The paper itself

Abstract

We describe ProteomeTools, a project building molecular and digital tools from the human proteome to facilitate biomedical research. Here we report the generation and multimodal liquid chromatography-tandem mass spectrometry analysis of >330,000 synthetic tryptic peptides representing essentially all canonical human gene products, and we exemplify the utility of these data in several applications. The resource (available at http://www.proteometools.org) will be extended to >1 million peptides, and all data will be shared with the community via ProteomicsDB and ProteomeXchange.

Indexed as

Chromatography, LiquidDatabases, ProteinGenome, HumanHumansProteomeProteomicsTandem Mass SpectrometryProteome

Identifiers

PMID28135259
PMCPMC5868332

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.